Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells-Reference-Cited by-同舟云学术

Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells

Published:2013-08 Issue:1 Volume:141 Page:55-65
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Catania Angela,Barrajón-Catalán Enrique,Nicolosi Silvia,Cicirata Federico,Micol Vicente

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-013-2667-y.pdf

Reference43 articles.

1. Yamamoto T et al (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319(6050):230–234

2. Bargmann CI, Hung MC, Weinberg RA (1986) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319(6050):226–230

3. Press MF, Cordon-Cardo C, Slamon DJ (1990) Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 5(7):953–962

4. Venter DJ, Fau-Tuzi NL et al (1987) Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet 2:69–72

5. Mitchell MS, Press MF (1999) The role of immunohistochemistry and fluorescence in situ hybridization for HER-2/neu in assessing the prognosis of breast cancer. Semin Oncol 26(4 Suppl. 12):108–116

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent;Pharmaceuticals;2024-01-18

2. Curcumin for Treating Breast Cancer: A Review of Molecular Mechanisms, Combinations with Anticancer Drugs, and Nanosystems;Pharmaceutics;2024-01-05

3. Physico-chemical properties of curcumin nanoparticles and its efficacy against Ehrlich ascites carcinoma;Scientific Reports;2023-11-24

4. Nanocarriers and their Role in the Treatment of Breast Cancer;Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective;2023-03-05

5. Immunoliposomes as an emerging nanocarrier for breast cancer therapy;European Polymer Journal;2023-02